The Director of Strategic Partnerships for NAS is responsible for successfully leading and growing our corporate sponsorships program. The goal is to identify partners that want to help us impact the advancement of our candidates in development as well as monetization. Securing partners that help NAS achieve the goals of the company as well as bring successful treatments to bedside soonest for patients that critically need them is our absolute goal. ResponsibilitiesDevelop effective strategies to engage new corporate relationshipsSet goals and direction of the programsDevelop structure of the business model including, but not limited to, development strategy, relationship management strategy, and retention strategyIdentify, contact, and build strong relationships with companies that are interested in associating themselves with our assetsLead the sponsorship team with integrity, passion, and a commitment to the missionCommunicate with team on a regular basisCreate sponsorship packages that benefit all involvedDevelop a renewal strategy to retain and grow relationships with current partnersFormalize agreements with each participating sponsorContinually evaluate program to ensure effectiveness and identify new opportunities for growthhttp://www.marketwatch.com/story/nas911-being-evaluated-as-co-therapeutic-for-treatment-of-influenza-2014-08-06

Foresight Capital Corporation is not comprised of traditional investment bankers, but rather facilitators and financial managers for growing companies. Our expertise is in resolving the complex and tedious details of equity funding that devour a CEO and CFO's time, energy, and focus. We provide private equity and debt funding from affiliated funds and through our syndicate for institutional and private investors. We bring a turnkey process to access public equity funding while enabling our clients to concentrate on growing their businesses.Consulting engagements include:PROJECT FINANCING AND CORPORATE GUIDANCE TO INCLUDE RESEARCH, PARTNERSHIPS, INVESTOR RELATIONS, ETC.EXISTING & ACTIVE PROJECTS 2022-2024:NEW AMSTERDAM SCIENCES, INC.LIPID NANOSCIENCES, INC. BIOCELLGRAFT, INC.FORESIGHT CAPITAL CORPORATIONUNNAMED VETERINARY HEALTH CLIENT TBA by end of Q3 2024Represent company interests on the East and West Coasts in order to expand corporate portfolio of contacts and investors. ▪ Coordinated, executed, and managed the funding efforts of approximately $80M dollars for assets of $5B in energy and natural resources.▪ Professional liaison and key investor relations contact. Builds confidence in the minds of new investors through evolving and up-to-the-minute communications, extensive research, and creative problem solving tailored to individual investor needs.Secured initial capital from private sector. Defined, implemented, and facilitated business and scientific strategies. Cultivated relationships with government biotech companies, pharmaceutical companies, academic institutions, and policy organizations. Liaised with government counter terrorism and health agencies.▪ Recruited industry leaders and developed outstanding oncology, dermatology, and drug development advisory boards vital to the success of groundbreaking research.▪ Instrumental in the passing of BARDA, the Biodefense and Pandemic Vaccine and Drug Development Act.